These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 25645552)
1. Angiotensin II: a new approach for refractory shock management? Kimmoun A; Levy B Crit Care; 2014 Dec; 18(6):694. PubMed ID: 25645552 [TBL] [Abstract][Full Text] [Related]
2. Treatment of hypotension in septic shock. Pastor CM; Morel DR Lancet; 1996 Mar; 347(9001):622; author reply 622-3. PubMed ID: 8596355 [No Abstract] [Full Text] [Related]
3. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II in septic shock. Jadhav AP; Sadaka FG Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784 [TBL] [Abstract][Full Text] [Related]
5. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock. Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016 [TBL] [Abstract][Full Text] [Related]
12. Refractory septic shock: efficacy and safety of very high doses of norepinephrine. Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448 [TBL] [Abstract][Full Text] [Related]
13. Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data. Abril MK; Khanna AK; Kroll S; McNamara C; Handisides D; Busse LW J Crit Care; 2019 Apr; 50():188-194. PubMed ID: 30553989 [TBL] [Abstract][Full Text] [Related]
14. THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW). Rurua M; Machavariani K; Sanikidze T; Shoshiashvili V; Pachkoria E; Ratiani L Georgian Med News; 2022 Feb; (323):157-161. PubMed ID: 35271489 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock. Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560 [TBL] [Abstract][Full Text] [Related]
16. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure. Conrad M; Perez P; Thivilier C; Levy B J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257 [TBL] [Abstract][Full Text] [Related]
17. Vasopressor weaning in patients with septic shock. Arellano DL; Hanneman SK Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693 [TBL] [Abstract][Full Text] [Related]
18. Vasodilatory shock in the ICU and the role of angiotensin II. Wakefield BJ; Sacha GL; Khanna AK Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia. Bui AD; Helgeson SA; Guru PK; Sanghavi DK BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32595128 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin II in septic shock. Corrêa TD; Takala J; Jakob SM Crit Care; 2015 Mar; 19(1):98. PubMed ID: 25886853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]